FOR PATIENTS
Personalized Cancer Immunotherapy Access Through the Right to Try Program
Through the federal Right to Try program, Elios Therapeutics makes investigational cancer immunotherapy available to eligible patients, a treatment uniquely created from your own tumor tissue to help your immune system fight your cancer.
What is the TLPO Vaccine?
TLPO is a personalized cancer vaccine produced from your own tumor tissue.
The problem: Your immune system often doesn't recognize cancer cells because they originated from your own body.
The solution: We use your tumor tissue to create a vaccine that teaches your immune system to attack your cancer cells.
The process:
-
Discuss this program with your treating physician
-
Your treating physician will schedule you for the collection of the necessary tumor sample to produce the TLPO vaccine
-
Your sample will be shipped to our lab for processing (additional shipping fee via Cryoport). Note: Storage does not obligate you to treatment.
-
The vaccine is administered as an intradermal injection
-
A 30-minute stay follows each dose for your safety monitoring
It's personalized medicine designed specifically for your unique cancer.
What is Right-to-Try?
The federal Right toTry Act (2018) allows patients with life-threatening conditions to access investigational treatments that have completed Phase 1 testing but aren't yet FDA-approved.
This program may be an option if:
-
Standard of care treatments haven't worked
-
You don't qualify for clinical trials
-
You have discontinued treatments because of toxicity and or side effects
-
You're seeking innovative approaches
Important: This is an investigational treatment, not FDA-approved. Your physician will help determine if it's right for you.
Getting Started: Three Simple Steps
1. TALK TO YOUR PHYSICIAN: Your doctor will determine if this treatment is right for you and submit a request on your behalf.
2. REVIEW & APPROVAL: We'll review the request within 4 business days and coordinate next steps with your doctor.
3. TISSUE COLLECTION & MANUFACTURING: Your surgical team will collect tumor tissue, and we'll create your personalized vaccine within approximately 6-8 weeks.
Your Investment in Treatment
-
The total out-of-pocket cost for manufacturing the vaccines is $25,000*.
-
Payment is due after your tissue sample is confirmed viable and before manufacturing begins.
-
We'll provide a detailed invoice and coordinate payment timing with you.
-
Discuss all costs with your physician and financial advisor to understand your complete investment.
*Additional costs may include administration and monitoring by your medical team; tumor collection and shipping*
Frequently Asked Questions
How long does the entire process take?
The time from physician request to vaccine administration is typically 6-8 weeks, depending on tissue collection timing.
What happens if my tissue sample isn't viable?
We'll notify you and your physician immediately.
Will my insurance cover this treatment?
As an investigational treatment under Right to Try, it's typically not covered by insurance. The patient is responsible for the $25,000 cost.
What is included in the $25,000 cost?
This covers personalized vaccine manufacturing only. Additional costs may include surgery, tissue shipping, vaccine administration, and medical monitoring; discuss with your physician.
Can I continue other treatments while waiting?
Your physician will guide you on this based on your specific situation. Generally, ongoing care continues during the manufacturing period.
Get in touch.
If you've exhausted standard of care treatments and are seeking new options, talk to your physician about whether the TLPO vaccine through Right to Try may be appropriate for you.
We understand the urgency you face and are here to support you and your medical team throughout this journey.
Contact Elios Therapeutics